NCT01876238
Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer No drug interventions supportive_care Not Available completed NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT00669565
Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer treatment 2 completed NCT03511781
Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer No drug interventions treatment Not Available completed NCT00433095
Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer treatment 2 completed NCT01531764
BIBW 2992 (Afatinib) and Vinorelbine treatment 2 terminated NCT02183805
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer treatment 2 terminated NCT02161315
Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer No drug interventions Not Available Not Available unknown_status NCT02140437
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC treatment 2 withdrawn NCT06281860
Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration No drug interventions treatment 1 recruiting NCT02755272
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer treatment 2 active_not_recruiting NCT01906112
Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. No drug interventions treatment 3 withdrawn NCT00199212
PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 treatment 1 completed NCT06246968
A Study of Pembrolizumab and Cryoablation in People with Breast Cancer treatment 1 recruiting NCT05036252
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity No drug interventions Not Available Not Available recruiting NCT04697043
The Benefit of Surgery in Stage IV of Breast Cancer No drug interventions treatment Not Available unknown_status NCT05625087
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib treatment 2 recruiting NCT05670054
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients No drug interventions treatment 3 recruiting NCT05559528
BRaziLian outcomE for metAStatic breasT Cancer No drug interventions Not Available Not Available recruiting NCT02448771
A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer treatment 1 / 2 completed NCT06234488
Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study No drug interventions Not Available Not Available active_not_recruiting NCT04133207
Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy No drug interventions Not Available Not Available completed NCT03401359
The Resistance and Immune Response to Palbociclib in Breast Cancer No drug interventions basic_science Not Available unknown_status NCT04150042
SHARON: A Clinical Trial for Metastatic Cancer With a BRCA or PALB2 Mutation Using Chemotherapy and Patients' Own Stem Cells treatment 1 recruiting NCT00393341
Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer No drug interventions Not Available Not Available completed NCT04566458
RWD Study in HER2+ mBC Patients in Third-Line Therapy No drug interventions Not Available Not Available completed NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy No drug interventions treatment 2 recruiting NCT05054374
A Study of Mirdametinib on Its Own or in Combination With Fulvestrant in People With Solid Tumor Cancer treatment 1 / 2 completed NCT04896320
Tucatinib With Chemotherapy and Trastuzumab in Advanced Her-2-neu Overexpressing, Previously Treated Breast Cancer. treatment 1 / 2 withdrawn NCT04469127
A Phase I/II Multicenter, Open-Label Study of Lu-177-DOTAGA-IAC, for the Treatment of Angiogenic Breast Cancer Patients. No drug interventions treatment 1 / 2 not_yet_recruiting NCT04123704
Sitravatinib in Metastatic Breast Cancer treatment 2 terminated NCT06236269
HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan diagnostic 2 recruiting NCT03304210
PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer treatment 1 completed NCT04852081
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study. Not Available Not Available unknown_status NCT03032614
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients treatment 2 withdrawn NCT05837533
Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients No drug interventions other Not Available recruiting NCT06481553
RWS of Paclitaxel Liposome Combined With Anti-HER-2 Monoclonal Antibody No drug interventions Not Available Not Available active_not_recruiting NCT05377047
Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer No drug interventions treatment Not Available recruiting NCT05860907
Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis No drug interventions treatment 4 not_yet_recruiting NCT03159585
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors No drug interventions treatment 1 completed NCT05866432
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases treatment 2 recruiting NCT04752059
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases treatment 2 completed NCT05190770
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer treatment 2 completed NCT06578299
Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer treatment 4 not_yet_recruiting NCT04628806
Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells No drug interventions Not Available Not Available unknown_status NCT03870919
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients treatment Not Available active_not_recruiting NCT05090358
Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer treatment 2 active_not_recruiting NCT05033925
Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients No drug interventions supportive_care 1 / 2 recruiting NCT03324425
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer treatment 2 active_not_recruiting NCT03339765
Self-Advocacy Serious Game in Advanced Cancer No drug interventions supportive_care Not Available completed NCT05880394
Study of Dotatate Imaging in Breast Cancer diagnostic 2 active_not_recruiting NCT03045289
A Whole-food, Plant-Based Nutrition Intervention in Women With Metastatic Breast Cancer No drug interventions treatment Not Available completed NCT03202446
Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer treatment 3 terminated NCT06075810
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer No drug interventions treatment 1 recruiting NCT05959291
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer No drug interventions diagnostic Not Available recruiting NCT01249443
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection treatment 1 terminated NCT03206203
Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer treatment 2 active_not_recruiting NCT01037790
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer treatment 2 completed NCT02370264
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer No drug interventions supportive_care Not Available terminated NCT06361264
Clinical Study of Personalized Chemotherapy for Breast Cancer With Low Doses of Cyclophosphamide No drug interventions treatment 0 recruiting NCT02046421
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT01922921
Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy treatment 1 / 2 completed NCT00992602
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer treatment 2 completed NCT00132002
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer treatment 2 terminated NCT03070002
Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells treatment 2 terminated NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video Calling No drug interventions supportive_care 1 completed NCT01941784
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy No drug interventions supportive_care Not Available completed NCT04298333
Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer supportive_care 1 completed NCT01730833
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer treatment 2 active_not_recruiting NCT00436254
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer treatment 1 active_not_recruiting NCT00003454
Antineoplaston Therapy in Treating Women With Stage IV Breast Cancer treatment 2 terminated NCT00024154
Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer treatment 1 completed NCT02648477
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer treatment 2 completed NCT03683147
Mindfulness-Based Stress Reduction in Helping Participants With Metastatic Breast Cancer No drug interventions supportive_care Not Available completed NCT04670445
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer No drug interventions health_services_research Not Available active_not_recruiting NCT01263145
MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer treatment 1 completed NCT02077998
Oxaliplatin in Treating Patients With Metastatic Breast Cancer treatment 0 completed NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT01245205
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer treatment 1 completed NCT00098605
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases treatment 2 completed NCT03603197
BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer treatment 2 completed NCT01009983
Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer treatment 2 terminated NCT01292083
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery treatment Not Available withdrawn NCT01288261
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer treatment 1 completed NCT06439693
The SAPPHO Study: A Single-Arm, Phase II Study of Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer treatment 2 not_yet_recruiting NCT01558778
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant No drug interventions supportive_care Not Available withdrawn NCT00004888
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer treatment 2 completed NCT00095888
3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer treatment 2 terminated NCT00068588
GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00316407
Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients treatment 1 / 2 completed NCT00559507
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT03971409
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer treatment 2 recruiting NCT00343109
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer prevention 2 completed NCT03566485
Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer treatment 1 / 2 terminated NCT00030615
Decitabine in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT00791037
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT01729832
Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer No drug interventions supportive_care Not Available withdrawn NCT00054132
Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer treatment 2 completed NCT02273752
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer treatment 2 terminated NCT00331552
Doxorubicin Hydrochloride Liposome, Cyclophosphamide, and Trastuzumab in Treating Patients With Stage IV Breast Cancer treatment 1 / 2 completed NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer treatment 2 active_not_recruiting NCT01104259
Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer treatment 1 completed NCT02015559
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus No drug interventions supportive_care 2 completed NCT02672475
Galunisertib and Paclitaxel in Treating Patients With Metastatic Androgen Receptor Negative (AR-) Triple Negative Breast Cancer treatment 1 completed NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy diagnostic 1 / 2 completed NCT05229575
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients No drug interventions treatment Not Available unknown_status NCT02824575
Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer treatment 1 terminated NCT00368875
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer treatment 1 / 2 completed NCT04267575
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites No drug interventions treatment Not Available unknown_status NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT01339442
BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer treatment 1 completed NCT00071942
Vaccine Therapy in Treating Patients With Metastatic Breast Cancer No drug interventions treatment 1 terminated NCT00003199
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer treatment 2 completed NCT00348699
AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery No drug interventions treatment 1 completed NCT00217399
Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer treatment 1 / 2 completed NCT00146549
Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer treatment 3 completed NCT00003536
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer treatment 2 withdrawn NCT00378313
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer treatment 2 completed NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer treatment 1 terminated NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT00057941
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer treatment 2 completed NCT01897441
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer treatment Not Available active_not_recruiting NCT00005817
Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer treatment 2 completed NCT00096434
Sorafenib in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00063934
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer treatment 1 / 2 terminated NCT02892734
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer treatment 2 terminated NCT01131234
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01276496
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery treatment 1 completed NCT00028496
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer treatment 1 completed NCT03222258
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients No drug interventions Not Available Not Available completed NCT03139435
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer No drug interventions diagnostic Not Available completed NCT01816035
Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT02650635
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors treatment 1 terminated NCT01042535
Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer treatment 1 / 2 completed NCT00053339
Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer treatment 3 withdrawn NCT01881230
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) treatment 2 / 3 completed NCT01881048
Window of Opportunity Study Targeting the Inflammatory Milieu treatment 0 active_not_recruiting NCT03364348
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer treatment 1 completed NCT01277757
Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer treatment 2 completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT01084057
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer treatment 1 completed NCT00079326
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer treatment 2 terminated NCT01987726
Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid Tumors No drug interventions Not Available Not Available completed NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors treatment 1 completed NCT04199520
Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients No drug interventions treatment 2 withdrawn NCT00937482
Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer treatment 1 terminated NCT02226276
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer diagnostic Not Available active_not_recruiting NCT00017394
Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer treatment 2 completed NCT02783794
BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer treatment 2 completed NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy diagnostic 2 completed NCT01846091
Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer treatment 1 completed NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer treatment Not Available completed NCT01730729
Cabergoline in Metastatic Breast Cancer treatment 0 completed NCT02657889
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer treatment 1 / 2 completed NCT02013492
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery treatment 0 completed NCT00003440
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic treatment 3 completed NCT01159067
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload supportive_care 2 terminated NCT01908101
Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer treatment 2 completed NCT01051401
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer treatment 1 terminated NCT00060372
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer treatment 1 completed NCT01153672
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy treatment Not Available completed NCT01986569
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer No drug interventions diagnostic 3 completed NCT02120469
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer treatment 1 completed NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer treatment 2 completed NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer treatment 1 completed NCT02038010
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx treatment 1 completed NCT02774681
Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis treatment 2 terminated NCT00031681
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) treatment 1 completed NCT00244881
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202) treatment 2 completed NCT00408681
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant supportive_care Not Available completed NCT01124695
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer treatment 2 completed NCT00194714
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab treatment 1 / 2 completed NCT00003455
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer treatment 2 withdrawn NCT00369655
VEGF Trap in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT00100750
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer treatment 1 / 2 completed NCT00998738
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer supportive_care 3 terminated NCT00602043
F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer No drug interventions diagnostic 2 completed NCT03154190
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer No drug interventions health_services_research Not Available unknown_status NCT01071564
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery treatment 1 terminated NCT00821964
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer treatment 2 completed NCT01390064
Vaccination of High Risk Breast Cancer Patients treatment 1 completed NCT01720602
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy treatment Not Available completed NCT01729884
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer treatment 2 terminated NCT00025584
PS-341 in Treating Women With Metastatic Breast Cancer treatment 2 completed NCT00509587
Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer treatment 2 completed NCT01938833
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer treatment 1 / 2 terminated NCT01873833
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer treatment 2 terminated NCT01113554
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors No drug interventions treatment Not Available completed NCT01487954
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy No drug interventions supportive_care 2 completed NCT02157051
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer No drug interventions treatment 1 active_not_recruiting NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast Cancer No drug interventions treatment Not Available terminated NCT00030498
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction treatment 1 completed NCT01741597
Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung diagnostic 1 withdrawn NCT00098397
FR901228 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01939483
A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases treatment Not Available withdrawn NCT00055861
Bevacizumab and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer treatment 2 completed NCT00054028
Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer treatment 1 / 2 completed NCT00006228
Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT05840211
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy treatment 3 active_not_recruiting NCT01217411
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer treatment 1 terminated NCT01697293
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer treatment 1 / 2 terminated NCT01355393
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer treatment 1 / 2 completed NCT01791478
BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer treatment 1 active_not_recruiting NCT00407888
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery treatment 2 completed NCT01349088
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer treatment 1 / 2 withdrawn NCT00045188
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer treatment 2 completed NCT01219907
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer treatment 1 withdrawn NCT00096109
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer treatment 2 terminated NCT01861509
BP-C1 in Metastatic Breast Cancer Patients No drug interventions basic_science 1 completed NCT01783756
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis treatment 1 / 2 completed NCT01149356
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer treatment 1 terminated NCT01712815
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer No drug interventions diagnostic Not Available terminated NCT01706432
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer No drug interventions Not Available Not Available completed NCT01242800
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer No drug interventions treatment Not Available completed NCT00520975
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU treatment 3 terminated NCT03455270
G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer treatment 1 completed NCT02269670
Phase II Study of Everolimus Beyond Progression treatment 2 terminated NCT01918306
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer treatment 1 / 2 terminated NCT00258349
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer treatment 1 / 2 completed NCT01151449
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer treatment 2 terminated NCT03789019
BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment treatment 2 completed NCT01243541
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel No drug interventions supportive_care Not Available terminated NCT03213041
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer treatment 2 recruiting NCT02206334
Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer No drug interventions treatment 1 completed NCT01964924
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer treatment 2 completed NCT04113096
Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer No drug interventions treatment 0 unknown_status NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) No drug interventions health_services_research Not Available completed NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT00228358
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine treatment 1 completed NCT01281163
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer treatment 1 terminated NCT00077363
Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer treatment 2 completed NCT00577122
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer treatment 2 completed NCT01575522
Tivantinib in Treating Patients With Recurrent or Metastatic Breast Cancer treatment 2 completed NCT03044730
Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery treatment 2 unknown_status NCT05025748
Ask Questions (ASQ):Implementation of a Communication Intervention No drug interventions health_services_research Not Available completed NCT00118157
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen treatment 2 completed NCT00004074
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu treatment 1 completed NCT00077376
Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer treatment 2 completed NCT00016276
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer treatment 3 terminated NCT02536794
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer treatment 2 completed NCT01307891
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer treatment 2 completed NCT02219789
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery treatment 1 completed NCT01705340
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery treatment 1 terminated NCT00182767
Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer treatment 1 / 2 completed NCT00425672
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment treatment 1 / 2 completed NCT03112668
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners No drug interventions supportive_care Not Available completed NCT00795769
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant supportive_care 2 completed NCT01093612
Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer No drug interventions diagnostic Not Available active_not_recruiting NCT02331212
Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer No drug interventions Not Available Not Available withdrawn NCT02457910
Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer treatment 1 / 2 terminated NCT00039455
Trastuzumab and Flavopiridol in Treating Patients With Metastatic Breast Cancer treatment 1 terminated NCT03749850
Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer treatment 1 unknown_status NCT01281150
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT00733408
Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer treatment 2 completed